How Cancer Metastasis Works and Why It's So Deadly

The Deadliest Phase of Cancer

Most cancer deaths are not caused by the original tumor. They are caused by metastasis — the process by which cancer cells break away from where they first formed, travel through the body, and establish new tumors in distant organs. According to the National Cancer Institute, metastasis is responsible for more than 90% of all cancer-related mortality. Understanding how it happens is central to the search for better treatments.

Step 1: Escape From the Primary Tumor

Cancer cells in a primary tumor are initially held in place by molecular anchors — proteins that bind them to neighboring cells and to the surrounding tissue scaffold known as the extracellular matrix (ECM). To metastasize, cells must first break these bonds.

This is achieved through a process called epithelial-to-mesenchymal transition (EMT). Epithelial cells — the type that lines organs — normally cling tightly together. Under the influence of genetic mutations or signaling molecules, cancer cells can switch to a mesenchymal state: they lose their adhesion properties, become elongated and mobile, and start producing enzymes called matrix metalloproteinases (MMPs) that digest the ECM like molecular scissors, carving a path for escape.

Step 2: Entering the Bloodstream

Once free, cancer cells must enter the circulatory or lymphatic system — a step called intravasation. Tumors often stimulate the growth of new, poorly structured blood vessels (a process called angiogenesis), which are leakier than normal vessels and easier to penetrate. Cancer cells push through the vessel wall using protrusive structures called invadopodia and slip into the bloodstream as circulating tumor cells (CTCs).

Survival in the bloodstream is brutally difficult. Most CTCs are destroyed within hours by mechanical shear forces and immune cells. Only a tiny fraction survives — but even a single cell that succeeds can be enough to seed a new tumor.

Step 3: Arriving at a New Organ

When a CTC gets stuck in a small capillary at a distant site, it faces its next challenge: crossing back out of the vessel and invading the surrounding tissue. This reverse journey is called extravasation. Integrins — proteins on the surface of cancer cells — grip the vessel wall, and the cell squeezes through tight junctions in the endothelium into the foreign tissue.

Cancer does not spread randomly. Different cancers have characteristic patterns: breast cancer frequently spreads to bone, lung, liver, and brain; prostate cancer favors bone; colon cancer tends to colonize the liver. This is sometimes called the "seed and soil" hypothesis — certain cancer cells (seeds) preferentially colonize certain organs (soil) whose environment suits them.

Step 4: Dormancy — The Silent Threat

Many cancer cells that reach distant sites do not immediately form tumors. Instead, they enter a state of dormancy, lying silent for months, years, or even decades. This explains why some patients who appear cancer-free after surgery relapse many years later. According to research published in Cancer Cell Dormancy in Metastasis (PMC), dormant cells resist therapy because they are not actively dividing — most cancer drugs target rapidly dividing cells. When conditions change — stress, immune suppression, aging — dormant cells can reawaken and proliferate.

Step 5: Colonization and Growth

For a metastatic cell to become a clinically dangerous tumor, it must colonize its new environment. It needs to evade local immune defenses, stimulate new blood vessel growth to feed itself, and reprogram the surrounding cells into a supportive "tumor microenvironment." This final step — colonization — is where the vast majority of metastatic attempts fail. Only a small fraction of disseminated cells ever succeed.

Why Metastasis Is So Hard to Treat

Several factors conspire to make metastatic cancer extraordinarily difficult to treat:

• Early escape: Cancer cells can disseminate before the primary tumor is even detectable, meaning surgery on the original site may not prevent spread.
• Low cell numbers: Disseminated tumor cells are present in vanishingly small numbers, making them nearly impossible to detect and target.
• Dormancy: Dormant cells are largely invisible to standard chemotherapy, which kills dividing cells.
• Genetic diversity: Metastatic tumors accumulate new mutations, often becoming resistant to drugs that worked against the original tumor.

Research published in Signal Transduction and Targeted Therapy describes the metastatic cascade as a series of "bottlenecks" — each step eliminates most cancer cells, but the rare survivors are the most dangerous. Understanding each bottleneck offers a potential target for new drugs. Therapies aimed at blocking EMT, preventing intravasation, or keeping dormant cells permanently asleep are all active areas of research.

The Road Ahead

Metastasis is not a single event but a complex biological program refined over millions of years of cancer evolution. Each step — invasion, intravasation, survival in circulation, extravasation, dormancy, colonization — represents both a biological obstacle and a potential therapeutic opportunity. As scientists map the molecular mechanisms in ever finer detail, the hope is to intercept cancer not just at its origin, but at every stage of its journey through the body.